Asterion (Drug Discovery) Overview
- Year Founded
-
2000
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Asterion (Drug Discovery) General Information
Description
Developer of a novel therapeutic drug designed to help in the treatment of serious chronic and acute disorders. The company's drug is made by applying engineering techniques that have long-acting potent biopharmaceuticals that require frequent administration than existing marketed drugs, enabling patients to have improved healthcare outcomes.
Contact Information
Website
www.asterion.co.ukCorporate Office
- The Innovation Centre
- 217 Portobello
- Sheffield S1 4DP
- England, United Kingdom
Corporate Office
- The Innovation Centre
- 217 Portobello
- Sheffield S1 4DP
- England, United Kingdom
Asterion (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 14-Sep-2021 | Completed | Out of Business | |||
| 5. Secondary Transaction - Private | 01-Jun-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 26-Mar-2008 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 12-May-2006 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-May-2006 | Completed | Startup | |||
| 1. Seed Round | 01-Feb-2001 | Completed | Startup |
Asterion (Drug Discovery) Patents
Asterion (Drug Discovery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201520021-D0 | Fusion polypeptide | Inactive | 13-Nov-2015 | ||
| GB-201617799-D0 | Fusion polypeptide | Inactive | 13-Nov-2015 | ||
| GB-201713537-D0 | Fusion polypeptide | Inactive | 13-Nov-2015 | ||
| GB-2549351-A | Fusion polypeptide | Inactive | 13-Nov-2015 | ||
| GB-2550792-A | Fusion polypeptide | Inactive | 13-Nov-2015 | C07K14/535 |
Asterion (Drug Discovery) FAQs
-
When was Asterion (Drug Discovery) founded?
Asterion (Drug Discovery) was founded in 2000.
-
Where is Asterion (Drug Discovery) headquartered?
Asterion (Drug Discovery) is headquartered in Sheffield, United Kingdom.
-
What industry is Asterion (Drug Discovery) in?
Asterion (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Asterion (Drug Discovery) a private or public company?
Asterion (Drug Discovery) is a Private company.
-
What is Asterion (Drug Discovery)’s current revenue?
The current revenue for Asterion (Drug Discovery) is .
-
How much funding has Asterion (Drug Discovery) raised over time?
Asterion (Drug Discovery) has raised $1.18M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process